Suppr超能文献

早期糖尿病中血小板聚集增加。

Increased platelet aggregation in early diabetus mellitus.

作者信息

Sagel J, Colwell J A, Crook L, Laimins M

出版信息

Ann Intern Med. 1975 Jun;82(6):733-8. doi: 10.7326/0003-4819-82-6-733.

Abstract

In view of the tendency toward vascular disease in diabetes mellitus, we studied platelet aggregation in 15 normal, 7 prediabetic, 12 latent, and 20 frankly diabetic subjects. Platelets from latent and frank diabetics showed increased platelet aggregation 4 minutes after adding adenosine 5'-diphosphate (60% verus 29% at 1.0 mu-M), epinephrine (46% versus 14% at 0.25 mu-M), and collagen (72% versus 17% at 0.25 mu-g/ml). Three prediabetics had increased platelet aggregation. Platelet sensitivity to aggregating agents was most marked in frank diabetics, intermediate in latent diabetics, and least in prediabetics. Second-phase platelet aggregation was reversed with acetylsalicylic acid, intravenous tolbutamide, and oral glucose administration. We conclude that platelet aggregation may be increased early in diabetes mellitus and may be involved in the genesis of diabetic microangiopathy. Prospective studies on the effect of therapeutic agents such as acetylsalicylic acid on the natural course of diabetic vascular disease are indicated.

摘要

鉴于糖尿病患者有患血管疾病的倾向,我们对15名正常受试者、7名糖尿病前期患者、12名潜伏性糖尿病患者和20名显性糖尿病患者的血小板聚集情况进行了研究。潜伏性糖尿病患者和显性糖尿病患者的血小板在加入5'-二磷酸腺苷(1.0微摩尔时,分别为60%和29%)、肾上腺素(0.25微摩尔时,分别为46%和14%)和胶原蛋白(0.25微克/毫升时,分别为72%和17%)4分钟后,血小板聚集增加。3名糖尿病前期患者的血小板聚集增加。血小板对聚集剂的敏感性在显性糖尿病患者中最为明显,在潜伏性糖尿病患者中居中,在糖尿病前期患者中最低。用乙酰水杨酸、静脉注射甲苯磺丁脲和口服葡萄糖可逆转二期血小板聚集。我们得出结论,糖尿病早期血小板聚集可能增加,并且可能参与糖尿病微血管病变的发生。有必要对乙酰水杨酸等治疗药物对糖尿病血管疾病自然病程的影响进行前瞻性研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验